Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Skin Cancer01:30

Skin Cancer

Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Lentigo maligna: melanoma in situ on chronically sun-damaged skin.

Archives of pathology & laboratory medicine·2011
Same author

The recurrent nevus phenomenon: a history of challenge, controversy, and discovery.

Archives of pathology & laboratory medicine·2011
Same author

Lymphotropism of Merkel cell polyomavirus infection, Nova Scotia, Canada.

Emerging infectious diseases·2010
Same author

Adipophilin expression in sebaceous tumors and other cutaneous lesions with clear cell histology: an immunohistochemical study of 117 cases.

Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc·2010
Same author

COL1A1:PDGFB chimeric transcripts are not present in indeterminate fibrohistiocytic lesions of the skin.

The American Journal of dermatopathology·2009
Same author

SKI knockdown inhibits human melanoma tumor growth in vivo.

Pigment cell & melanoma research·2009
Same journal

Blastic Plasmacytoid Dendritic Cell Neoplasm.

Journal of cutaneous pathology·2026
Same journal

Atypical Grover Disease Associated With Merkel Cell Carcinoma: A Novel Paraneoplastic Presentation.

Journal of cutaneous pathology·2026
Same journal

Profile of a Founder: Herbert Zachareus Lund.

Journal of cutaneous pathology·2026
Same journal

The National Resident Match Program Arrives in Dermatopathology: 15 Years of Resilient Advocacy by the American Society of Dermatopathology's Fellowship Training Program Directors' Committee.

Journal of cutaneous pathology·2026
Same journal

Evaluating Large Language Models for Melanocytic Lesion Pathology Report Interpretation.

Journal of cutaneous pathology·2026
Same journal

An Atypical Skin Presentation of Adult-Onset Still's Disease With Histological Description: A Case Report.

Journal of cutaneous pathology·2026
See all related articles

Related Experiment Video

Updated: Jun 28, 2026

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis
07:41

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis

Published on: March 8, 2022

Deciphering the melanoma interactome.

Jon A Reed1

  • 1Section of Dermatopathology, Department of Pathology, Baylor College of Medicine, Houston, TX 77030, USA. jreed@bcm.edu

Journal of Cutaneous Pathology
|November 6, 2008
PubMed
Summary
This summary is machine-generated.

Investigating melanoma

More Related Videos

A 3D Organotypic Melanoma Spheroid Skin Model
08:49

A 3D Organotypic Melanoma Spheroid Skin Model

Published on: May 18, 2018

Screening for Melanoma Modifiers using a Zebrafish Autochthonous Tumor Model
10:23

Screening for Melanoma Modifiers using a Zebrafish Autochthonous Tumor Model

Published on: November 13, 2012

Related Experiment Videos

Last Updated: Jun 28, 2026

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis
07:41

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis

Published on: March 8, 2022

A 3D Organotypic Melanoma Spheroid Skin Model
08:49

A 3D Organotypic Melanoma Spheroid Skin Model

Published on: May 18, 2018

Screening for Melanoma Modifiers using a Zebrafish Autochthonous Tumor Model
10:23

Screening for Melanoma Modifiers using a Zebrafish Autochthonous Tumor Model

Published on: November 13, 2012

Area of Science:

  • Oncology
  • Dermatology
  • Molecular Biology

Background:

  • Late-stage malignant melanoma presents a significant therapeutic challenge.
  • Recent advances have improved understanding of melanoma's molecular and genetic pathways.
  • Early electron microscopy studies laid groundwork for current molecular pathology approaches.

Purpose of the Study:

  • To review proteins contributing to the melanoma 'interactome'.
  • To explore aberrant signaling pathways in melanoma.
  • To identify potential targets for novel advanced melanoma therapies.

Main Methods:

  • Review of existing literature on melanoma molecular pathology.
  • Analysis of aberrant cellular signaling pathways.
  • Focus on key proteins within the melanoma interactome.

Main Results:

  • Identified key proteins implicated in melanoma development and progression.
  • Highlighted the role of aberrant signaling pathway interactions.
  • Emphasized the significance of the 'interactome' in melanoma.

Conclusions:

  • Understanding melanoma signaling networks is crucial for therapeutic development.
  • Targeting specific proteins in the interactome may offer new treatment strategies.
  • Further research into the melanoma interactome is warranted.